Resources

Knowledge Center
Filter
Blogs
Case Studies
Data
Factsheets
Govt. Strategies, Plans, and Documents
High-Impact Practices
Infographics
Meeting Documents
Newsletters
Presentations
Publications
Q&A
Remarks
Toolkits
Videos and Webinars
Website and Portals
Advocacy & Awareness
Contraceptive Security
Financing
Innovation
Policy and Enabling Environment
Rights
Service Delivery & Quality
Young People
Commitment Maker
Country
Commitment Maker
Country
Date: 11/07/2017
Source: My Social Good News
Type: Data
In 2016, a total of 81 contraceptive social marketing programs generated 74.9 million Couple Years of Protection (CYPs), an increase of over 7 million CYPs in 2015, to couples, women and girls around the world, according to the 2016 Contraceptive Social Marketing (CSM) Statistics report just published by DKT International. This included sales of over 1.8 billion condoms, 45 million injectables, 1...
Date: 10/31/2017
Source: Evidence2Action
Type: Case Studies
To help address the unmet demand for contraception among Ethiopian youth, E2A, in collaboration with the Integrated Family Health Program Plus (IFHP+), tested a model that strengthened family planning service delivery at youth-friendly service sites by readying the sites to provide adolescents and youth full contraceptive choice including long-acting reversible contraceptives (LARCs). The study...
Date: 10/30/2017
Source: Guttmacher Institute
Type: Publications
A new research approach provides evidence that can be used to hold governments accountable for the success of public programs in satisfying demand for family planning, according to “The Role of Public-Sector Family Planning Programs in Meeting the Demand for Contraception in Sub-Saharan Africa,” by John Bongaarts and Karen Hardee of the Population Council. The article, which examines data from...
Date: 10/30/2017
Source: PATH
Type: Case Studies , Videos and Webinars
Access to a range of contraceptive choices allows each woman to find an option that works best for her. The all-in-one injectable contraceptive, subcutaneous DMPA* (DMPA-SC, marketed as Pfizer’s Sayana® Press**) can overcome access barriers by enabling health worker administration in new and remote locations, and even self-injection. Between 2017 and 2020, the Subcutaneous DMPA Access...
Date: 10/30/2017
Source: PATH
Type: Case Studies
New evidence indicates that self-injected contraception could make a significant impact in addressing high contraceptive discontinuation rates. Results from a recent FHI 360 study in Malawi showed that self-injection led to a more than 50 percent increase in continuous DMPA-SC use over 12 months compared to provider administration. FHI 360, through the US Agency for International Development’s...
Can we help you find something?
Blogs
Case Studies
Data
Factsheets
Govt. Strategies, Plans, and Documents
High-Impact Practices
Infographics
Meeting Documents
Newsletters
Presentations
Publications
Q&A
Remarks
Toolkits
Videos and Webinars
Website and Portals
Advocacy & Awareness
Contraceptive Security
Financing
Innovation
Policy and Enabling Environment
Rights
Service Delivery & Quality
Young People
Commitment Maker
Country
Commitment Maker
Country